Literature DB >> 15743668

Stem cell: balancing aging and cancer.

Ana Krtolica1.   

Abstract

Stem cells are defined by their self-renewing capacity and the ability to differentiate into one or more cell types. Stem cells can be divided, depending on their origin, into embryonic or adult. Embryonic stem cells derive from early stage embryos and can give rise to cells from all three germ layers. Adult stem cells, first identified in hematopoietic tissue, reside in a variety of adult tissues. Under normal physiologic conditions, adult stem cells are capable of differentiating into the limited cell types that comprise the particular tissue or organ. Adult stem cells are responsible for tissue renewal and exhaustion of their replicative capacity may contribute to tissue aging. Loss of unlimited proliferative capacity in some of the adult stem cells and/or their progenitors may have involved the evolutionary trade-off: senescence prevents cancer but may promote aging. Embryonic stem cells exhibit unlimited self-renewal capacity due to the expression of telomerase. Although they possess some cancer cell characteristics, embryonic stem cells exhibit a remarkable resistance to genomic instability and malignant transformation. Understanding the tumor suppressive mechanisms employed by embryonic stem cells may contribute to the development of novel cancer treatments and safe cell-based therapies for age-related diseases.

Entities:  

Mesh:

Year:  2004        PMID: 15743668     DOI: 10.1016/j.biocel.2004.10.007

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  14 in total

Review 1.  Corneal epithelial stem cells in health and disease.

Authors:  Julie T Daniels; Anna R Harris; Chris Mason
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 2.  Potential for access to embryonic-like cells from human umbilical cord blood.

Authors:  C P McGuckin; N Forraz
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

Review 3.  The human brain and its neural stem cells postmortem: from dead brains to live therapy.

Authors:  Robert E Feldmann; Rainer Mattern
Journal:  Int J Legal Med       Date:  2005-10-07       Impact factor: 2.686

4.  Changes in gene expression associated with aging commonly originate during juvenile growth.

Authors:  Julian C Lui; Weiping Chen; Kevin M Barnes; Jeffrey Baron
Journal:  Mech Ageing Dev       Date:  2010-09-09       Impact factor: 5.432

Review 5.  Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.

Authors:  Yoav Shetzer; Alina Molchadsky; Varda Rotter
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

6.  A cancer-causing gene is positively correlated with male aggression in Xiphophorus cortezi.

Authors:  A A Fernandez
Journal:  J Evol Biol       Date:  2009-12-15       Impact factor: 2.411

7.  Reciprocal intraepithelial interactions between TP63 and hedgehog signaling regulate quiescence and activation of progenitor elaboration by mammary stem cells.

Authors:  Na Li; Samer Singh; Pratima Cherukuri; Hua Li; Ziqiang Yuan; Leif W Ellisen; Baolin Wang; David Robbins; James DiRenzo
Journal:  Stem Cells       Date:  2008-02-21       Impact factor: 6.277

8.  Quantitative analysis of mitotic Olig2 cells in adult human brain and gliomas: implications for glioma histogenesis and biology.

Authors:  Wootack Rhee; Sutapa Ray; Hideaki Yokoo; Megan E Hoane; Chong C Lee; Andrei M Mikheev; Philip J Horner; Robert C Rostomily
Journal:  Glia       Date:  2009-04-01       Impact factor: 7.452

Review 9.  Tumor suppressive pathways in the control of neurogenesis.

Authors:  Stefano Bartesaghi; Paolo Salomoni
Journal:  Cell Mol Life Sci       Date:  2012-07-17       Impact factor: 9.261

10.  Maintenance of genomic stability in mouse embryonic stem cells: relevance in aging and disease.

Authors:  Claudia Giachino; Luca Orlando; Valentina Turinetto
Journal:  Int J Mol Sci       Date:  2013-01-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.